Sam Collins

Sam Collins

Sam Collins is  InvestorPlace.com’s Chief Technical Analyst. He has more than four decades of experience in Wall Street firms.

In addition to providing fundamental and technical analysis for InvestorPlace.com, he provides FREE daily market commentary each trading day via the Daily Trader’s Alert. The Daily Trader’s Alert contains his Daily Market Outlook PLUS a Trade of the Day.

Sam served as a regular army captain serving in West Germany during the Berlin Wall Crisis before joining Merrill Lynch as a futures broker. Since then, he has been a financial adviser, branch manager, regional manager and certified portfolio manager with national and regional securities firms. While he retired in October 2009, during his career, he received recognition and numerous awards.

Sam used technical analysis as a timing and selection technique with portfolios that he managed. He developed a specific technical analysis technique and timing system called the Collins Bollinger Reversal (CBR) that has received national recognition, and he has appeared on local and national TV as a financial commentator.

As an equity specialist and technician, he uses technical analysis as a selection technique along with fundamental analysis. As a value buyer, his goal is to find companies with outstanding management, unique products and strong financials that have not yet been driven to unreasonable prices. His CBR system helps him to screen vast amounts of data for stocks that meet those standards.

Sam is also a member of the NASD Board of Arbitrators.

Recent Articles

Small Caps Look Like Traders’ Strongest Bet

The Russell 2000 broke to new highs and, therefore, has no resistance standing in its way.

The Bull Has 3 Days to Prove Itself

Most technicians look for a strong positive follow-through within five-10 days of a big pop, and Friday was the seventh day.

Sam Collins’ No. 1 Sector for 2013

The First Trust ISE Cloud Computing Index Fund (NYSE:SKYY) was met with criticism when it launched in 2011, but I think it could provide investors with a huge return.

2 Sectors the Charts Say Will Be Top Performers in 2013

The technicals point to financials and builders as being big winners this year.

Don’t Get Fooled by This Drugmaker’s Chart

Eli Lilly may look like it is approaching a formidable double-top, but momentum and volume should carry it higher. Get the target for LLY.

Don’t Sell This Dull Market

The chances of a near-term breakout are improving.

Only Aggressive Investors Should Buy Now

Those who take long positions here should be willing to ride out a correction.

Top Biotech Powering Higher on Breakout

Celgene Corp. (NASDAQ:CELG) broke from a cup-and-handle followed by a breakaway gap.

The Bull is Alive and Well in This Overbought Market

The market is flush with cash and strong technical signals.

Price Target Raised for 8% Yielding MLP

Rentech Nitrogen broke from a consolidation and could add another leg to its bull market. Get the target for RNF.